Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function
September 19, 2024 15:10 ET
|
Novo Nordisk A/S
Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® (semaglutide 2.4 mg) is the first...
Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers
September 19, 2024 13:30 ET
|
UsAgainstAlzheimer's
New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and...
Indkaldelse til ordinær generalforsamling 2024
September 18, 2024 08:45 ET
|
Chemometec A/S
MEDDELELSE NR. 275 18. september 2024 Indkaldelse til ordinær generalforsamling Vedlagt offentliggøres selskabets indkaldelse til ordinær generalforsamling, som afholdes...
nextSource and Worksome Form Strategic Partnership to Revolutionize Freelance Workforce Solutions
September 17, 2024 12:04 ET
|
nextSource
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- nextSource, a leading Managed Services Provider (MSP), along with Worksome, a leader in freelance workforce operations, today announced a new strategic...
American Kidney Fund Hosts Annual National Summit on Unknown Causes of Kidney Disease
September 16, 2024 09:49 ET
|
American Kidney Fund
ROCKVILLE, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- As part of its ongoing groundbreaking work to advance understanding and patient care of undiagnosed or misdiagnosed causes of kidney disease, the...
Novo Nordisk A/S - share repurchase programme
September 16, 2024 09:15 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 16 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
September 16, 2024 08:00 ET
|
Korro Bio, Inc.
Partnership leverages Korro’s proprietary OPERATM platform to enable its oligonucleotide-directed RNA edits into two undisclosed targets; initially for cardiometabolic diseases Total deal value of up...
NFL Alumni & Giants Great Victor Cruz Team Up To Celebrate Hispanic Heritage Month
September 12, 2024 12:09 ET
|
NFL Alumni
MOUNT LAUREL, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The National Football League Alumni Association (NFLA) and its members are honored to celebrate Hispanic Heritage Month by expanding its...
IPGaia and the Icahn School of Medicine at Mount Sinai Announce Comprehensive Collaborative Research and Development Agreement
September 10, 2024 10:37 ET
|
Mount Sinai Press Office
New York, NY, Sept. 10, 2024 (GLOBE NEWSWIRE) -- IPGaia Inc. ("IPG") and the Icahn School of Medicine at Mount Sinai (“Icahn Mount Sinai”) have entered into a Comprehensive Collaborative Research...
Growth Hormone Deficiency Market Size to Hit USD 8.5 Billion by 2032 | SNS Insider
September 10, 2024 09:00 ET
|
SNS Insider pvt ltd
Pune, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Growth Hormone Deficiency Market Size & Share Analysis: “According to SNS Insider, The Growth hormone deficiency Market was valued at USD 5.4 billion...